Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction

Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction

BackgroundData about real-world effects of combined therapy with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure (HF) with reduced ejection fraction (HFrEF) has not been widely reported. In this article, the benefits of dapagliflozin and sacubitril/valsartan respect to...

Full description

Bibliographic Details
Main Authors: Juan Jiang, Jie Gao, Xiuzhen Zhang, Yuanmin Li, Heqin Dang, Yanlin Liu, Wenwen Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
heart failure
sacubitril/valsartan
dapagliflozin
combined therapy
effect
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1097066/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1097066/full

Similar Items